Staphylococcus Aureus Enterotoxin Type B anticorps
L’anticorps Souris Monoclonal anti-Staphylococcus Aureus Enterotoxin Type B a été validé pour EIA. Il convient pour détecter Staphylococcus Aureus Enterotoxin Type B dans des échantillons de Staphylococcus aureus.
N° du produit ABIN5542128
Aperçu rapide pour Staphylococcus Aureus Enterotoxin Type B anticorps (ABIN5542128)
Antigène
Staphylococcus Aureus Enterotoxin Type B
(Staphylococcus Aureus Enterotoxin B)
Reactivité
Staphylococcus aureus
Hôte
Souris
Clonalité
Monoclonal
Conjugué
Cet anticorp Staphylococcus Aureus Enterotoxin Type B est non-conjugé
Reactivité: Staphylococcus, Bactéries
IF (cc), IF (p)
Hôte: Lapin
Polyclonal
AbBy Fluor® 594
Indications d'application
ELISA. This Staphylococcal Enterotoxin B (Clone SEB) as a superantigen for T-lymphocytes is a potential targeting antigen in cancer immunotherapy. It has been suggested that monoclonal antibody to SEB has been useful in immunotherapy research.
Restrictions
For Research Use only
Buffer
0.01M PBS, pH 7.2 without preservatives
Agent conservateur
Without preservative
Stock
4 °C,-20 °C
Stockage commentaire
Prior to reconstitution store at 2-8°C. Following reconstitution store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
Date de péremption
12 months
Antigène
Staphylococcus Aureus Enterotoxin Type B
(Staphylococcus Aureus Enterotoxin B)
Sujet
Staphylococcal enterotoxin B (SEB) is an enterotoxin secreted by Staphylococcus aureus. The bacterium thrives on meet, baking and dairy products and also colonizes in host nasal passageway. Ingestion of SEB contaminated food is the common cause of "food poisoning", manifested by flu-like symptoms, vomiting, diarrhea and intestinal cramps. In severe cases, SEB can cause respiratory failure and systemic toxic shock. These symptoms are the results of increased membrane permeability and abnormal activation of Tlymphocytes by SEB. SEB acts as a superantigen by binding directly to major histocompatibility complex class II (MHCII) on antigen presenting cells, thus, causing massive CD4 and CD8 Tcells activation and cytokine production. If unchecked, the process can result in systemic organ failure and death.